Literature DB >> 12073754

Smoking-related costs among 25 to 59 year-old males in a 19-year individual follow-up.

Urpo Kiiskinen1, Erkki Vartiainen, Pekka Puska, Markku Pekurinen.   

Abstract

OBJECTIVE: To estimate the health care expenditure and productivity losses due to smoking.
DESIGN: A retrospective cohort study of a random population sample of 5,247 men aged 25-59 years from the provinces of Kuopio and North Karelia in eastern Finland. Subjects initially surveyed in 1972 were linked to a set of national registers through their social security identification numbers and followed for 19 years. The difference in the number of life years and work years lost, the costs of drugs and hospitalization, and the value of productivity lost due to disability and premature mortality between smokers, former smokers and never-smokers was analysed.
RESULTS: The difference in mean life expectancy between current smokers and never-smokers was 3.0 years, and the difference in mean lost work time was 2.6 years over the 19 years of follow-up. Between current smokers and former smokers, the difference in mean life expectancy was 1.8 years, and the difference in mean lost work time was 1.6 years. The mean difference between a current smoker and a never-smoker in health service costs was [symbol: see text] 2,900, and the difference in mean total costs was [symbol: see text] 69,300 (an increase of 86%). No difference in mean health care costs between current smokers and former-smokers was found, while the difference in mean total cost was [symbol: see text] 44,000.
CONCLUSIONS: Smokers incurred excess costs in terms of both direct health care expenditure and indirect productivity losses in comparison to the never-smoking population. Most importantly, quitting smoking could save at least 60% of the losses related to excess mortality and disability of smokers.

Entities:  

Mesh:

Year:  2002        PMID: 12073754     DOI: 10.1093/eurpub/12.2.145

Source DB:  PubMed          Journal:  Eur J Public Health        ISSN: 1101-1262            Impact factor:   3.367


  5 in total

1.  The effect of smoking on years of healthy life (YHL) lost among middle-aged and older Americans.

Authors:  Truls Østbye; Donald H Taylor
Journal:  Health Serv Res       Date:  2004-06       Impact factor: 3.402

2.  Cost effectiveness of varenicline in Belgium, compared with bupropion, nicotine replacement therapy, brief counselling and unaided smoking cessation: a BENESCO Markov cost-effectiveness analysis.

Authors:  Lieven Annemans; Kristiaan Nackaerts; Pierre Bartsch; Jacques Prignot; Sophie Marbaix
Journal:  Clin Drug Investig       Date:  2009       Impact factor: 2.859

3.  The net effect of smoking on healthcare and welfare costs. A cohort study.

Authors:  Jari Tiihonen; Kimmo Ronkainen; Aki Kangasharju; Jussi Kauhanen
Journal:  BMJ Open       Date:  2012-12-11       Impact factor: 2.692

4.  The association of smoking status with healthcare utilisation, productivity loss and resulting costs: results from the population-based KORA F4 study.

Authors:  Margarethe Wacker; Rolf Holle; Joachim Heinrich; Karl-Heinz Ladwig; Annette Peters; Reiner Leidl; Petra Menn
Journal:  BMC Health Serv Res       Date:  2013-07-17       Impact factor: 2.655

5.  Productivity burden of smoking in Australia: a life table modelling study.

Authors:  Alice J Owen; Salsabil B Maulida; Ella Zomer; Danny Liew
Journal:  Tob Control       Date:  2018-07-16       Impact factor: 7.552

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.